The incidence of idiopathic pulmonary fibrosis (IPF) has doubled over the past decade.

There are 50,000 IPF deaths per year in the U.S. alone; more than from breast cancer

The CDC identified a cluster of IPF patients at a Virginia medical center: see here

What we do

We advocate and fund raise for the most promising research to accelerate cures for Idiopathic Pulmonary Fibrosis (IPF).  

We support the CleanUP IPF Trial

We are pleased to report that the CleanUP IPF Trial – the largest National Institutes of Health (NIH) sponsored trial in IPF – is now at full capacity. 

However, there is much work ahead for our researchers. 

We want to thank all of the IPF patients who volunteered to participate in the CleanUP IPF trial and the broader IPF community for helping to spread the word about this innovative study investigating antibiotics in patients.

 “If micro-organisms are triggering and/or sustaining the disease and we are able to figure this out, then a cure should be in sight.”

Dr. Jerry Eu, Former Program Director, Immunology/Fibrosis at the NIH (2016)

100% of your online donation goes to CleanUP IPF Trial

Our foundation is laser focused, solely committed to supporting pulmonary fibrosis research.